If you cannot see this email please follow this link.
Newsletter Regulatory Affairs
Your monthly regulatory affairs update
{Anrede},

welcome to the February 2025 issue of the regulatory affairs newsletter. Today you will receive an overview of regulatory issues of the last few weeks and a summary of the Online Pharma FORUM Webcast on the Topic: "The New German Medical Research Act".
Editorial
News from ICH
News from European Commission
News from EMA
Veterinary news
Monthly reports
Editorial

Author: Dr Michaela Gottwald, FORUM Institut für Management GmbH

On 13 January 2025, a webcast took place as part of the Online Pharma FORUM, this time on the topic of "The New German Medical Research Act".
... Read more


News from ICH
The ICH E6(R3) "Good Clinical Practice" Guideline reaches Step 4 of the ICH process. It provides a unified standard to facilitate the mutual acceptance of clinical trial data for ICH member countries and regions by applicable regulatory authorities
Details


News from European Commission
The European Commission published the new EU rules on EU-HTA.
Details


The European Commission published the EU-HTA implementation plan.
Details


The EU Commission published the outcome of the PICO exercises (EU-HTA).
Details

Dr Paul de Boissieu (HAS) addresses the topic "Joint clinical assessment according to the implementing act" at the course "JCA Dossiers & Joint Clinical Assessments"
Details



The Joint Action on Respiratory Diseases (JARED) will hold its kick-off meeting. JARED is a three-year collaboration between 14 Member States, Iceland, Ukraine and Moldova, led by Hungary and will focus on tackling chronic respiratory diseases (CRDs).
Details


News from EMA
The first full version of the European Shortages Monitoring Platform (ESMP) became available on 29 January 2025. To access the platform, please follow the link:
Details


From now on all clinical trials in the European Union (EU), including ongoing trials that were approved under the previous legal framework, the Clinical Trials Directive (CTD), are governed by the Clinical Trials Regulation (CTR).
Details


The Draft reflection paper "on the use of information in European Union herbal monographs and assessment reports for borderline issues" can be commented on by 1 May 2025.
Details


EMA has published an EU-IN Horizon Scanning Report on "Nanotechnology-based medicinal products for human use".
Details


PharmaFORUM Webcast International - More information >>


Veterinary news
The draft reflection paper "on the qualification of non-mutagenic impurities" can be commented on by 30 April 2025.
Details


EMA published a concept paper for the development of a guideline on quality aspects of mRNA vaccines for veterinary use. It can be commented on by 8 April 2025.
Details


Monthly reports
PRAC
Details


CHMP
Details


CMDh
Details


CVMP
Details



Kind regards,

Dr Rebekka Bitsch
Your contact for
Regulatory Affairs (Human)
+49 6221 500-565
Dr C. Michaela Gottwald
Your contact for
Regulatory Affairs (Veterinary)
+49 6221 500-610
Dr Birgit Wessels
Your contact for
CMC
+49 6221 500-652


Verena Planitz
Your contact for
Global Regulatory Affairs
+49 6221 500-655

TO UNSUBSCRIBE:
If you do not want to receive this information in future, you can unsubscribe here!
FORUM ⋅ Institut für Management GmbH ⋅ Vangerowstr. 18 ⋅ 69115 Heidelberg ⋅ Germany
Fon +49 6221 500-500 ⋅ Fax +49 6221 500-555 ⋅ service@forum-institut.de www.forum-institut.com
Copyright 2025 FORUM ⋅ Institut für Management GmbH
Imprint, privacy policy, terms and conditions

We guarantee the highest quality with ISO 9001 and ISO 21001 certifications.
Nachhaltigkeit